Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -Q1 group results

Aug 2 (Reuters)-  
             Taisho Pharmaceutical Holdings Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               68.53               69.43           279.00     
                   (-1.3 pct)          (+0.3 pct)       (-0.3 pct)   
  Operating            6.94                9.11            28.50     
                   (-23.8 pct)         (+74.0 pct)      (-10.8 pct)  
  Recurring            8.80               10.42            34.50     
                   (-15.6 pct)         (+39.1 pct)      (-9.3 pct)   
  Net                  5.53                6.95            24.00     
                   (-20.3 pct)         (+48.2 pct)      (-16.6 pct)  
  EPS               69.27 yen           86.92 yen       300.38 yen   
  EPS Diluted       69.21 yen           86.86 yen                    
  Ann Div                              110.00 yen       110.00 yen   
  -Q2 div                               50.00 yen        50.00 yen   
  -Q4 div                               60.00 yen        60.00 yen   
   
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Taisho Pharmaceutical Holdings Co

See all news